510(k) Report

510(k) · Cleared

Cleared

Fast'n'flammatory Kit

K931241510(k) TraditionalCleared Feb 3, 1994329-day reviewClass I21 CFR 864.7675

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Techlab, Inc. · GIA Test, Leukocyte Peroxidase

Cleared on Feb 3, 1994 after a 329-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 1 later device descends from it.

Decided
Feb 3, 1994
Review
329 days
Class
Class I
Product code
GIA
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared1990200020102020
  1. This deviceK931241 Fast'n'flammatory KitTechlab, Inc. · 1994
  2. Descendant · cites it directly · 0 of its ownK071712 Leuko EZ VueTechlab Inc., Corporate Research Center · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K071712Leuko EZ VueTechlab Inc., Corporate Research Center · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K931241Fast'n'flammatory KitTechlab, Inc.1994—
+1K071712Leuko EZ VueTechlab Inc., Corporate Research Center2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K931241, 1994–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GIA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071712Leuko EZ VueTechlab Inc., Corporate Research Center20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K071712 (Techlab Inc., Corporate Research Center, 2007) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GIA devices

GIA Test, Leukocyte Peroxidase: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GIA

FDA has decided no GIA device since 2007.

Median 510(k) review, days · GIA

Too few GIA 510(k)s in any year since 2007 to give a median.

Recalls per year · GIA

No recall names GIA since 2007.

Adverse event reports per year · GIA

2in 2017

2017: 2
2007high 2 (2017) · low 0 (2007)2025

MAUDE reports naming product code GIA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—02
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K931241: Fast'n'flammatory Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K931241

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026